全文获取类型
收费全文 | 16621篇 |
免费 | 1463篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 120篇 |
儿科学 | 633篇 |
妇产科学 | 457篇 |
基础医学 | 2153篇 |
口腔科学 | 179篇 |
临床医学 | 2445篇 |
内科学 | 2764篇 |
皮肤病学 | 271篇 |
神经病学 | 1560篇 |
特种医学 | 475篇 |
外科学 | 1913篇 |
综合类 | 274篇 |
一般理论 | 16篇 |
预防医学 | 2303篇 |
眼科学 | 226篇 |
药学 | 1003篇 |
中国医学 | 18篇 |
肿瘤学 | 1293篇 |
出版年
2023年 | 116篇 |
2022年 | 84篇 |
2021年 | 281篇 |
2020年 | 180篇 |
2019年 | 348篇 |
2018年 | 346篇 |
2017年 | 274篇 |
2016年 | 274篇 |
2015年 | 335篇 |
2014年 | 493篇 |
2013年 | 727篇 |
2012年 | 1034篇 |
2011年 | 1120篇 |
2010年 | 611篇 |
2009年 | 517篇 |
2008年 | 971篇 |
2007年 | 1018篇 |
2006年 | 968篇 |
2005年 | 946篇 |
2004年 | 889篇 |
2003年 | 842篇 |
2002年 | 846篇 |
2001年 | 362篇 |
2000年 | 342篇 |
1999年 | 301篇 |
1998年 | 219篇 |
1997年 | 150篇 |
1996年 | 150篇 |
1995年 | 144篇 |
1994年 | 123篇 |
1993年 | 130篇 |
1992年 | 218篇 |
1991年 | 224篇 |
1990年 | 205篇 |
1989年 | 197篇 |
1988年 | 170篇 |
1987年 | 184篇 |
1986年 | 175篇 |
1985年 | 182篇 |
1984年 | 140篇 |
1983年 | 101篇 |
1982年 | 68篇 |
1981年 | 65篇 |
1980年 | 68篇 |
1979年 | 80篇 |
1978年 | 65篇 |
1977年 | 68篇 |
1975年 | 66篇 |
1974年 | 65篇 |
1973年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
3.
4.
5.
6.
7.
8.
9.
Anthony R. Flores Brittany E. Jewell Erika M. Versalovic Randall J. Olsen Beth A. Bachert Slawomir Lukomski James M. Musser 《Infection and immunity》2015,83(3):1122-1129
Group A Streptococcus (GAS) predominantly exists as a colonizer of the human oropharynx that occasionally breaches epithelial barriers to cause invasive diseases. Despite the frequency of GAS carriage, few investigations into the contributory molecular mechanisms exist. To this end, we identified a naturally occurring polymorphism in the gene encoding the streptococcal collagen-like protein A (SclA) in GAS carrier strains. All previously sequenced invasive serotype M3 GAS possess a premature stop codon in the sclA gene truncating the protein. The carrier polymorphism is predicted to restore SclA function and was infrequently identified by targeted DNA sequencing in invasive strains of the same serotype. We demonstrate that a strain with the carrier sclA allele expressed a full-length SclA protein, while the strain with the invasive sclA allele expressed a truncated variant. An isoallelic mutant invasive strain with the carrier sclA allele exhibited decreased virulence in a mouse model of invasive disease and decreased multiplication in human blood. Further, the isoallelic invasive strain with the carrier sclA allele persisted in the mouse nasopharynx and had increased adherence to cultured epithelial cells. Repair of the premature stop codon in the invasive sclA allele restored the ability to bind the extracellular matrix proteins laminin and cellular fibronectin. These data demonstrate that a mutation in GAS carrier strains increases adherence and decreases virulence and suggest selection against increased adherence in GAS invasive isolates. 相似文献
10.
John P. Sundberg Kathleen A. Silva Victoria E. Kennedy John J. Wilson Nicholas E. Gott Beth A. Sundberg Derry C. Roopenian 《Experimental dermatology》2019,28(9):1091-1093
2‐deoxy D‐glucose (2DG) was tested for efficacy in treating alopecia areata using the C3H/HeJ skin graft model. 2DG has proven to be efficacious in treatment of various mouse models of autoimmunity with minimal serious side effects noted. This agent has been shown to normalize abnormally activated T‐cell populations while also preventing cell surface expression of NKG2D; key factors defining alopecia areata disease progression. Daily oral ingestion of 2DG via drinking water to mice with patchy or diffuse alopecia areata for 16 weeks failed to prevent expansion of alopecia or cause regrowth of hair in treated mice. Histologically, there were no differences between treated and control groups. These results indicate that, while 2DG is effective for some autoimmune diseases, it was not efficacious for the cell‐mediated autoimmune mouse disease, alopecia areata. 相似文献